Email this article 
The activities of public organizations to reduce inequality in the availability of medicines to the population. Part 1. Accessibility of medicines to the population for sustainable development
- Authors: Vrubel M.E.1
- Affiliations:
- N. A. Semashko National Research Institute of Public Health, Moscow, Russian Federation
- Issue: No 1 (2024)
- Pages: 27-30
- Section: Articles
- URL: https://remedium-journal.ru/journal/article/view/1691
- DOI: https://doi.org/10.32687/1561-5936-2024-28-1-27-30
- Cite item
Abstract
One of the consequences of population aging, which is a global trend, is an increase in the use of medical services by elderly and senile citizens. These circumstances require that medical professionals have the appropriate competencies in the field of professional communication to effectively communicate with elderly patients in order to provide high-quality medical care. The presented work is aimed at studying the problems of communication «doctor — elderly patient» in the context of determining the characteristics of aging that affect the effectiveness of interaction with medical professionals.
About the authors
Maria E. Vrubel
N. A. Semashko National Research Institute of Public Health, Moscow, Russian Federation
Email: mariavrubel@gmail.ru
References
- Bigdeli M., Jacobs B., Thomson G. et al. Access to medicines from the point of view of the healthcare system. Health Policy Planning. 2013;28(7):692—704.;2. Ananchenkova P. I. Pharmacy tourism and reimport of medical products as a form of ensuring the availability of medicines. Remedium. 2022;26(3):225—228.;3. The World Health Organization. 2017. Ten years in the field of public health, 2007—2017. Geneva; 2019.;4. Telnova E. A. Analysis and assessment of the problems of drug supply in the Russian Federation in modern conditions. Problems of social hygiene, health care and the history of medicine. 2021;29(3):415—420.;5. WHO The selection of essential drugs: report of a WHO expert committee. Technical Report Series. 1977;(615).;6. Simao M., Wirtz V. J., Al-Ansary L. A. et al. A global accountability mechanism for access to essential medicines. Lancet. 2018;392:2418—2420.;7. Timakov I. V. Economic accessibility of medicines for Russian households. Population. 2023;26(4):177—189.;8. Hogercell H. V. Basic medicines and human rights: what can they learn from each other? Bulletin of the World Health Organization. 2006;84:371—375.;9. WHO Medicines Strategy 2004—2007: countries in the spotlight. The World Health Organization. 2004:13—16.;10. Increasing access to essential medicines in the developing world: UK Government policy and plans. L.; 2004:32—39.;11. World Health Organization. Quality assurance of pharmaceuticals: a compendium of guidelines and related materials. Good manufacturing practices and inspection. 2007;(2):20—27.;12. Hogercell H. Promoting the rational administration of medicines. Medical education. 1995;39:1—6.;13. World Health Organization. Promoting the rational use of medicines saves lives and money. WHO experts say. 2004:5—9.;14. Abbas N., Hassan S. S., Kerli L., Babar Z. U. Access to medicines — a systematic review of the literature. Research in Social & Administrative Pharmacy. 2020;16(9):1166—1176.;15. Leisinger K. M., Garabedyan L. F., Wagner A. K. Improving access to medicines in low- and middle-income countries: corporate responsibility in context. Southern Med. Review. 2012;5(2):3—8.;16. Zhao Yu., Mahal A. S., Haregu T. N. et al. Trends and inequalities in health care and hypertension outcomes in China, 2011—2015. Int. J. Environ. Res. Public Health. 2019;16(22):4578.
